BRIEF published on 06/11/2024 at 09:05, 2 years 1 month ago Medincell rejoint l'indice Euronext Tech Leaders Innovation Secteur Technologique Visibilité Des Investisseurs Médine Leaders Technologiques D'Euronext
PRESS RELEASE published on 06/11/2024 at 09:00, 2 years 1 month ago Inside Information / Other news releases Medincell joins Euronext Tech Leaders, gaining access to a broad investor base and support services. CEO Christophe Douat highlights the company's growth and tech innovation leadership Tech Sector Financial Strategy Investor Base Medincell Euronext Tech Leaders
PRESS RELEASE published on 06/11/2024 at 09:00, 2 years 1 month ago Informations privilégiées / Autres communiqués Medincell rejoint l’indice Euronext Tech Leaders, accédant à un vaste écosystème et renforçant sa visibilité auprès d'investisseurs internationaux. La technologie BEPO® innovante de Medincell est reconnue Croissance Innovation Medincell Euronext Tech Leaders BEPO®
BRIEF published on 05/10/2024 at 18:05, 2 years 2 months ago Medincell annonce les détails sur le capital et les droits de vote conformément à la réglementation Euronext Paris Droits De Vote Réglementation Financière Capital Social Medincell
BRIEF published on 05/10/2024 at 18:05, 2 years 2 months ago Medincell announces details on capital and voting rights in accordance with regulations Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
PRESS RELEASE published on 05/10/2024 at 18:00, 2 years 2 months ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 2 years 2 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 2 years 2 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 2 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
PRESS RELEASE published on 05/08/2024 at 12:30, 2 years 2 months ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
Published on 08/06/2026 at 11:00, 1 hour 57 minutes ago Blue Lagoon Files Annual Financial Statements and Provides Comment on Temporary Cease Trade Order
Published on 08/06/2026 at 08:05, 4 hours 52 minutes ago Tocvan Drills Significant Discovery On Mezquite Trend Gran Pilar 215M Of 0.6 G/T AU, From 36.6M Downhole
Published on 08/06/2026 at 03:35, 9 hours 22 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 11 hours 17 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 13 hours 17 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/06/2026 at 12:05, 52 minutes ago CULTURAL DISRUPTORS AND CULINARY ICONS UNVEILED AS THE GLOBAL JURY FOR THE S.PELLEGRINO YOUNG CHEF ACADEMY COMPETITION 2026-27
Published on 08/06/2026 at 11:30, 1 hour 27 minutes ago Partners Group to become majority shareholder in data center power solutions provider AVK and accelerate future growth
Published on 08/06/2026 at 11:05, 1 hour 52 minutes ago ABB invests in LevelTen Energy to advance clean energy procurement
Published on 08/06/2026 at 11:05, 1 hour 52 minutes ago IIFL Capital partners with Flytxt to leverage Agentic AI for sustainable AUM growth
Published on 08/06/2026 at 08:44, 4 hours 12 minutes ago IDI annonce la cession du groupe Talis à son fondateur, Serge Marcillaud, accompagné de l'équipe dirigeante
Published on 08/06/2026 at 08:00, 4 hours 57 minutes ago EURAZEO ENTRE EN DISCUSSIONS EXCLUSIVES AVEC PARTNERS GROUP EN VUE DE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET DE SON RÉINVESTISSEMENT À SES CÔTÉS
Published on 08/06/2026 at 08:00, 4 hours 57 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/06/2026 at 07:48, 5 hours 8 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 18:00, 18 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
